logo
logo
twitter facebook facebook
Mayur Kasrung
Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment.
twitter facebook facebook
India
Followers 2 Following 0
Mayur Kasrung 2021-08-23
img

Tissue Tranglutaminase (Ttg) Test Market: By Type (Serological, Biopsy, and others), and By End Users (Hospitals & Clinics, Homecare, Research Organisations, others) - Global Forecast Till 2027Market HighlightsThe tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease.

According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth.

likely to affect the market growth negatively.Global tTG testing MarketSome of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.

Additionally, concentration of major research companies and research organizations in the developed countries of this region boost the market growth.Europe is the second largest market in the world due to high income and healthcare penetration.Asia Pacific region is expected to grow rapidly.

China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market.

Introduction2.1 Definition2.2 Scope Of The Study2.2.1 Research Objective2.2.2 Assumptions2.2.3 Limitations2.3 Market Structure2.4.

collect
0
Mayur Kasrung 2021-08-21
img

Global salivary gland infection market information, by diagnosis (plain radiography, sialography, and others), by treatment (medication, surgery, aspiration, and others), by end user- Forecast till 2027Market HighlightsThe global salivary gland infection market has been evaluated as a moderately growing market and it is expected to continue growing in the near future.

Increasing prevalence of salivary gland infections are major driver for the market growth.

Some other factors such as changing disease patterns, smoking, and changing environment are driving the growth of global salivary gland infection market.The market for salivary gland infection was around USD 2300.8 million in 2016 and is expected to reach USD 3622.6 million which is projected to grow at a CAGR of 6.7% by 2023.Major players in Salivary Gland Infection market:There are plenty of large and small market players which operate in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc.

Drug manufactures are investing large amount of money in new product development as well as improvement of existing product to derive efficient solution for market.

Top players are holding majority of market share while medium and small companies are also holding small but major piece of this market.WOCKHARDT’s a global pharmaceutical and biotechnology organization is under clinical development of its Second-generation Ketolide drug which can treat serious bacterial infections.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3779Regional Analysis:Considering the global scenario of the salivary gland infection market, in 2016, Americas was holding the largest market share in global salivary gland infection.

US is dominating and top revenue generator in Americas market that is mainly due to some factors like increasing investment research and clinical trials.

collect
0
Mayur Kasrung 2021-08-17
img

Global Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2027Market HighlightsThe rising prevalence of angina and coronary heart diseases, growing healthcare expenditure, and increasing geriatric and obese population are expected to drive the global angina market, during the forecast period.

On the basis of treatment, the market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others.

The medication segment is sub-segmented into aspirin, clot-preventing drugs, statins, ranolazine, and others.

This can be attributed to the presence of a well-developed healthcare sector and a huge patient population for coronary heart diseases.

Availability of funds for research, growing number of obese and patient population, and the presence of developed economies such as France, Italy, and Germany within the region are the major drivers for the market growth within the region.

This can be attributed to the presence of poor economies, stringent government policies, and low per capita healthcare expenditure, especially within the African region.

collect
0
Mayur Kasrung 2021-08-17
img

Asia Pacific Orthopedic Biomaterial Market Information, By Type Of Material (Metal, Non-Metal), By Application (Joint Replacement, Fracture Fixation Devices, Tissue Fixation, Spine Implants Viscosupplementation, And Others), And By End Users (Hospital, Clinics) - Forecast Till 2027Market Insights:As per the latest study published by Market Research Future (MRFR), the Asia Pacific orthopedic biomaterial market is poised to strike a CAGR of 12.6% during the forecast period 2017 to 2023.

The growth of the orthopedic branch of medicine coupled with rising demand for biomaterials for implants is likely to drive the growth of the Asia Pacific orthopedic biomaterial market in the upcoming years.The advancements in the medical science over the years has catalyzed the adoption of biomaterials for implants and surgeries.

Furthermore, the extensive use of biomaterials for the treatment of internal fractures is another factor responsible for driving the expansion of the Asia Pacific orthopedic biomaterial market.The rising demand for knee and hip replacements coupled with increasing medical emergencies and bone injuries in the region are projected to have a favorable impact on the proliferation of the Asia Pacific orthopedic biomaterial market over the assessment period.Other factors that are estimated to accelerate the revenue creation for the participants of the Asia Pacific orthopedic material market include rising aging population, increasing orthopedic surgeries, initiatives undertaken by governments, etc.

Nevertheless, stringent regulation, the high cost of treatment and joint implant failures are expected to restrict the Asia Pacific orthopedic biomaterial market expansion over 2023.Market Segmentation:By material, the Asia Pacific orthopedic biomaterial market has been segmented into metals and non-metals.

The non-metal segment has been further sub-segmented into ceramic, polymeric, natural biomaterials, and others.

The fracture fixation devices segment is sub-segmented into screws, plates for bones, rods, and other.By end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/643Regional Analysis:China is the most significant country-level market in the region.

collect
0
Mayur Kasrung 2021-08-23
img

Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global Forecast Till 2027Market Highlights:Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart.

The market restraints are the poor cure rates, poor efficacy and efficiency of effective drugs etc.Global Wolff Parkinson White Syndrome Market PlayersKey players profiled in the report are AngioDynamics, Medtronic, Boston Scientific Corporation, St. Jude Medical, LLC, Abbott, GlaxoSmithKline LLC, Teva Pharmaceutical Industries, Sanofi S.A., and Novartis International AG and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4224Regional AnalysisThe Americas which are dominated by the US account for a significant market share owing to extensive use of medications and high expenditure on the health care.

Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Wolff Parkinson White syndrome market.

The good reimbursement scenario and the greater awareness in the developed regions drive the market.Europe is the second largest market in the world due to high income and healthcare penetration.

The presence of large screening programs in the developed regions drives the market for Wolff Parkinson White syndrome.Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market.

The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report.

collect
0
Mayur Kasrung 2021-08-17
img

Specialty Medical Chairs Market Research Report, by Product Type (Examination Chair, (Birthing, Cardiac), Treatment Chair (Ophthalmic, ENT), Rehabilitation Chair (Geriatric, Pediatric)), Application (Medical Units, Hospital) — Global Forecast till 2027Market HighlightsIt is estimated that the global specialty medical chairs market is expected to register a CAGR ~6.8% during the forecast period of 2018–2023.The global specialty medical chairs market is expected to witness tremendous growth owing to the increasing incidence of obesity and a large number of laparoscopic surgeries performed.

However, factors such as lack of trained medical professionals are expected to curb the growth of the market during the forecast period.An increasing number of patients requiring treatment and examination favors the growth of the market.On a regional basis, the specialty medical chairs market in the Americas is predicted to dominate the market during the forecast period.

For instance, according to the American Hospital Association (AHA), an annual survey of hospitals in the US suggests the total number of registered hospitals in the US was 5,534 in 2017.

Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market.Currently, the global specialty medical chairs market is dominated by numerous players.

The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio.

For instance, Dentsply Sirona, Inc. focusing on the development of new products, updating existing products, and introducing advanced technology in products.

collect
0
Mayur Kasrung 2021-08-17
img

Global Mitochondrial Myopathy Diagnosis & Treatment Market Research Report: Information by Type (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes, Progressive External Ophthalmoplegia, Myoclonic Epilepsy with Ragged Red Fibers, Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, Kearns–Sayre Syndrome (KSS), Mitochondrial DNA Depletion Syndrome, Pearson Syndrome, Leigh Syndrome, Neuropathy, Ataxia and others), Diagnostic Test (Genetic Tests, Muscle Biopsy and Biochemical Test), Deployment Models (On-Premise and Cloud-Based), Therapy (Supportive Therapy and Targeted Therapy) and Region - Forecast Till 2027In Mitochondrial myopathy, the mitochondria are affected which leads to symptoms such as muscle weakness, muscle cramping, low immunity, poor balance, and fatigue.

The spiraling rise in the incidence rate of mitochondrial myopathy is a key factor in boosting the growth of the market.

In addition, rigorous R activities aimed at developing therapies and treatments for mitochondrial myopathy have encouraged the growth of the market.

Lack of proper curative treatment and poor treatment options remain a major hurdle for the market growth.

Besides, the rare nature of the disease and high cost of drug development along with high investment risk remain major challenges to the growth of the market.

Nevertheless, faster market uptake and low marketing cost are likely to present growth opportunities to the global mitochondrial myopathy diagnosis & treatment market.SegmentationThe global mitochondrial myopathy diagnosis & treatment market has been segmented based on type, diagnostic tests, and therapy.By type, the global mitochondrial myopathy diagnosis & treatment market has been segmented into neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), progressive external ophthalmoplegia (PEO), Pearson syndrome, Leigh syndrome, ataxia, mitochondrial DNA depletion syndrome (MDS), Retinitis pigmentosa (NARP), Kearns–Sayre syndrome (KSS), myoclonic epilepsy with ragged red fibres (MERRF), mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE).

collect
0
Mayur Kasrung 2021-08-16
img

Global Hypotension Treatment Market Research Report: By Products (Blood Pressure Transducers, Sphygmomanometers, Blood Pressure Devices), By End-Users (Diagnostic Centers, Home Care, Hospitals & Clinics) and Regions (Europe, Americas, Middle East & Africa, Asia Pacific) – Forecast to 2027Industry Analysis:The worldwide low blood pressure or hypotension market is driven by various factors.

Dehydration, endocrine disorders, and nerve issues can also cause hypotension, leading to further market growth.

Low blood pressure patients often feel dizzy and weak, which is why, they are recommended several medicines to maintain stability and good health.Teenagers and post-partum mothers are also impacted by hypotension.

The presence of cardiac & diabetic patients has increased stress on developing & developed nations.

Some of the eminent companies spending capital on the hypotension treatment industry are Shire plc, Hoffman-La Roche Limited, and Amgen, Inc.

A novel drug, Droxidopa, sold as Northera, was sanctioned to manage multiple-system atrophy, Parkinson’s disease, and pure autonomic failures.

collect
0
Mayur Kasrung 2021-08-23
img

Tonsil cancer Market information: by type (squamous cell carcinoma, salivary gland cancer, and others), diagnosis (physical exam, imaging tests, and others), by treatment (surgery, radiation therapy, and others), by end user- global forecast till 2027The global market consist of players such as F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany), Amgen, Inc. (US), Eli Lilly and Company (US), AstraZeneca Plc.

As a result, the research and development activities in the oncology have intensified in last decade.According to National cancer Institute, in 2016, nearly 1,685,210 new cases of cancer were diagnosed in the United States and it was estimated that 595,690 people will die from the cancer.Tonsil cancer begins in the cells of tonsils.

Rise in the smoking, and alcohol consumption has increasd the risk of development of the tonsil cancer.

Lack of availability of a concrete treatment option has created a wide range of opportunities for the development of the market.

United States is said to have the best medical and healthcare facilities in the world.

As far as South America is concerned, the healthcare industry is still developing and expected to have a moderate growth during the forecast period.European tonsil cancer market is majorly fuelled by the rise in the smoking population and alcohol consumption.

collect
0
Mayur Kasrung 2021-08-17
img

Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific & the Middle East & Africa) - Global Forecast till 2027Market Research Future (MRFR) recognizes the following companies as the key players in the global prils market are Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG.Market HighlightsThe Prils Market is estimated to be valued at USD 2,591.5 million by 2023 and is expected to register a CAGR of 4.3% during the forecast period.Prils are small molecules or active pharmaceutical ingredients (API).

There are various types of APIs used by pharmaceutical companies to develop therapeutic products for the treatment of various chronic diseases such as hypertension, heart diseases, and kidney diseases.Segment analysisOn the basis of type, the global prils market is segmented into benazepril, cilazapril, quinapril, and ramipril.

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and mostly preferred drug for the treatment of hypertension.

The use of ramipril reduces the risk of stroke, heart attack, and also decreases kidney-related problems.

This drug normalizes blood vessels and offers normal blood flow.

Increasing smoking also causes cardiovascular diseases.

collect
0
Mayur Kasrung 2021-08-17
img

The global data analysis, storage & management market in life sciences is expected to register a CAGR of 12.0% during the forecast period and is expected to hit USD 43,895.69 million by 2027.Data analysis, storage, and management provides operational benefits to an organization by enhancing the efficiency of electronic data storage.

The data analysis, storage & management market in life sciences is growing due to the increasing government initiatives to increase the adoption of different data-based solutions and the growing demand for data storage and management solutions due to the extensive amount of data generated in the life science field.

Additionally, the increasing growth strategies adopted by major players are also driving the market growth.Segment AnalysisThe global data analysis, storage & management market in life sciences has been divided based on product & service, application, and end user.The market, based on product& service, has been segregated into data analysis software and workbenches, storage, management and cloud computing solution, data analysis services.Based on application,the medical testing market has been divided intobnext-generation sequencing, microscopy, chromatography, flow cytometry, spectroscopy, and others.On the basis of end user, the market is bifurcated into pharmaceutical and biotechnology companies, research centers, academic & government institutions, and hospitals & clinics.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/10317Regional AnalysisThe global data analysis, storage & management market in life sciences, based on region, has been divided into North America, Europe, Asia-Pacific, and the rest of the world.

North Americais expected to dominate with the largest market share due to a well-developed healthcare sector, the rising population affected with chronic diseases and other cardiovascular disorders, the growing use of big data in healthcare, and the presence of leading players.Europe held a significant share in the global data analysis, storage & management market in life sciences.

This can be attributed to the increasing support from the government, well-developed technology, high healthcare expenditure, the presence of the leading players, and rising adoption of big data analysis and cloud-based solutions.Asia-Pacific is expected to be the fastest-growing market due to the rapidly changing healthcare sector and huge opportunities for the development of this market.

Furthermore, the increase in per-capita healthcare expenditure, rise in diagnostic centers, and rapid urbanization in developing countries such as India are likely to witness an increase in the influx of the emigrant population.

collect
0
Mayur Kasrung 2021-08-16
img

Hallux Rigidus Market Research Report: By Treatment (Non-Surgical Treatment And Surgical Treatment), Diagnosis (X-Ray, Ct Scan, And Mri), End-Users (Hospitals & Surgical Centers, Home Cares, And Orthopedic Specialty Clinics) – Global Forecast Till 2027Market Highlights:Hallux rigidus is an arthritic condition often leading to pain and stiffness within the joint located behind the big toe.

It leads to limitation in joint range of motion and painful ambulation.The Global Hallux Rigidus Market is expected to grow at a CAGR of 7.6% during the forecast period.Regional Analysis:The Americas dominate the global hallux rigidus market owing to the rising geriatric population, increase in genetic disorders and increasing number of surgical procedures in the hospitals.

North America holds the largest market owing to extensive use of advanced technology and developed pharmaceutical sector.Europe accounts for the second largest market due to increasing funds, government support, and increasing healthcare expenditure.

Germany, France, and the U.K hold a significant share in the market due to increasing demand for technologically advanced devices for the surgical procedures and overall growth of medical device industry.The Asia Pacific is the fastest growing market for the hallux rigidus, whose growth is attributed to rising geriatric population, increasing prevalence of people suffering from toe infections, and rapidly developing economies.

For instance, according to ESCAPE (Economic and Social Commission for Asia and the Pacific), in the year 2016, approximately 12.4% of the population was 60 years or older and is projected to increase to 1.3 billion people by 2050.

India and China are the major contributors to the market growth due to the rapid development of healthcare sector in these regions and increasing demand for diagnostic services.On the other hand, the Middle East & Africa is expected to witness limited growth due to limited access to the healthcare resources and lack of awareness about rare diseases.

collect
0
Mayur Kasrung 2021-08-21
img

Vesicoureteral Reflux Market Research Information: by types (primary, secondary) by diagnosis (cystography, VCUG, others) by drug treatment (quinolones, aminoglycosides, others) by surgery (open, robotic, others) by end users - Global Forecast till 2027Market HighlightsVesicoureteral reflux (VUR), is a condition in which urine flows backward, from the bladder into the ureters/kidneys.

The normally flow of urine is unidirectional from the kidneys to the bladder via the ureters.

The backflow is prevented by a 1-way valve at the vesicoureteral junction.The market for Vesicoureteral reflux diagnosis and treatment is driven by factors such as growing prevalence of urinary tract infection, genetic predisposition and occurrence at birth (congenital), increasing screening etc.

Advances in surgical robots such as miniaturization improvements in planned and regulated movement, processing power etc.

Clinical benefits include reduced invasiveness, reduction of tissue trauma traditionally associated with open surgery, less surgeon fatigue due to better ergonomic position of the hands etc.

Product development strategy and growing awareness coupled with the rising penetration of healthcare will drive the market for Vesicoureteral reflux diagnosis and treatment.Request Free Sample Copy @ https://www.marketresearchfuture.com/reports/vesicoureteral-reflux-market-3982Global Vesicoureteral reflux market Players:Key players profiled in the report are Salix Pharmaceuticals, Q-Med Scandinavia Inc., Cook Medical, Salix Pharmaceuticals, Ltd., Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd and others.Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report.

collect
0
Mayur Kasrung 2021-08-17
img

Global Epilepsy Diagnosis & Treatment Market Research Report, By Type (Idiopathic, Cryptogenic, Symptomatic), Diagnosis (Neurological Exam, Blood Test, Imaging), Treatment (Medication, Surgery) End-User (Hospitals, Clinics) - Global Forecast Till 2027Market HighlightsIncreasing prevalence of epilepsy, rising number of traumatic brain injury cases, growing geriatric population, and rising healthcare expenditures are the major drivers for the global epilepsy diagnosis and treatment market.

However, high cost of therapeutic surgeries, low per capita healthcare expenditure, and lack of awareness for the disease in emerging economies are estimated to restrain the market growth during the projected period.

The imaging segment is sub-segmented into electroencephalogram, computerized tomography, magnetic resonance imaging, positron emission tomography, and others.

On the basis of treatment, the market is segmented into medication, surgery, brain stimulation, and others.

The brain stimulation segment is sub-segmented into deep brain stimulation, responsive neurostimulation, and others.

On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5647Regional AnalysisThe Americas dominate the global epilepsy diagnosis and treatment market, which can be attributed to the presence of a well-developed healthcare sector and huge patient population within the region.

collect
0
Mayur Kasrung 2021-08-17
img

LDL Test Market Information: By Types (LDL-C, LDL-P, LDL-B And Others) By Components (Devices, Kits & Reagents And Others) By Application (Atherosclerosis, Obesity, Dyslipidemia, Diabetes, Angina, Stroke, Carotid Artery Disease, Peripheral Arterial Disease, Others) And By End Users- Global Forecast Till 2027Market Highlights:LDL is referred as low-density lipoprotein, which is type of cholesterol found in body.

Low-density lipoprotein (LDL), often known as bad cholesterol, is a microscopic blob made up of an outer rim of lipoprotein and a cholesterol center.

It's bad because it becomes part of plaque, and that can clog arteries and make heart attacks and strokes more likely.

The global LDL test market is projected to grow at a CAGR of ~ 5.5 % during the forecast period 2017-2023.Key Market PlayersQuest Diagnostics Incorporated, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckon Diagnostics, DiaSys Diagnostics India Private Limited, F. Hoffmann-La Roche Ltd and others.

Also, major research and manufacturing companies are present in America.Europe is the second largest market in the world due to high income, government support for research & development and availability of resources.Asia Pacific region shows the fastest growth owing to the presence of huge population base, and continuous development in the healthcare sector.

The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.Taste the market data and market information presented through more than 55 market data tables and figures spread over 110 pages of the project report.

collect
0
Mayur Kasrung 2021-08-16
img

Global Phototherapy Market Research Report: Information By Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, Fiberoptic Phototherapy Equipment, Germicidal lamps and Accessories), Radiation (UVA, UVB and UVC), Application (Skin Disease Treatment, Neonatal Jaundice Management and Sterilization), End User (Hospital & Clinic, Dermatology Center and Homecare) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast to 2027Market OverviewGlobal Phototherapy Market is expected to reach USD 764.5 Million by 2027 at a CAGR of 4.61% during the forecast period.

Market Research Future (MRFR), in its report, offers an in-depth look into the market during the review period.Segmental AnalysisGlobal Phototherapy Market has been segmented based on Product, Radiation, Application, and End User.Based on product, the global phototherapy market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories.

The conventional phototherapy equipment segment dominated the market with a valuation of USD 184.0 million in 2019; it is expected to reach a valuation of USD 250.5 million by 2027.

The conventional phototherapy equipment comes with a fluorescent lamp for full-body or partial-body phototherapy.Based on radiation, the global phototherapy market has been classified into UVA, UVB, and UVC.

Narrowband UVB is frequently used because it is more effective for treating psoriasis than UVA or Broadband UVB.Based on application, the global phototherapy market has been classified into skin disease treatment, neonatal jaundice management, and sterilization.

Neonatal jaundice is referred to the yellowing of the skin and white part of the eyes of a new-born baby due to a high level of bilirubin.

collect
0
Mayur Kasrung 2021-08-23
img

Tissue Tranglutaminase (Ttg) Test Market: By Type (Serological, Biopsy, and others), and By End Users (Hospitals & Clinics, Homecare, Research Organisations, others) - Global Forecast Till 2027Market HighlightsThe tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease.

According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth.

likely to affect the market growth negatively.Global tTG testing MarketSome of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.

Additionally, concentration of major research companies and research organizations in the developed countries of this region boost the market growth.Europe is the second largest market in the world due to high income and healthcare penetration.Asia Pacific region is expected to grow rapidly.

China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market.

Introduction2.1 Definition2.2 Scope Of The Study2.2.1 Research Objective2.2.2 Assumptions2.2.3 Limitations2.3 Market Structure2.4.

Mayur Kasrung 2021-08-23
img

Tonsil cancer Market information: by type (squamous cell carcinoma, salivary gland cancer, and others), diagnosis (physical exam, imaging tests, and others), by treatment (surgery, radiation therapy, and others), by end user- global forecast till 2027The global market consist of players such as F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany), Amgen, Inc. (US), Eli Lilly and Company (US), AstraZeneca Plc.

As a result, the research and development activities in the oncology have intensified in last decade.According to National cancer Institute, in 2016, nearly 1,685,210 new cases of cancer were diagnosed in the United States and it was estimated that 595,690 people will die from the cancer.Tonsil cancer begins in the cells of tonsils.

Rise in the smoking, and alcohol consumption has increasd the risk of development of the tonsil cancer.

Lack of availability of a concrete treatment option has created a wide range of opportunities for the development of the market.

United States is said to have the best medical and healthcare facilities in the world.

As far as South America is concerned, the healthcare industry is still developing and expected to have a moderate growth during the forecast period.European tonsil cancer market is majorly fuelled by the rise in the smoking population and alcohol consumption.

Mayur Kasrung 2021-08-21
img

Global salivary gland infection market information, by diagnosis (plain radiography, sialography, and others), by treatment (medication, surgery, aspiration, and others), by end user- Forecast till 2027Market HighlightsThe global salivary gland infection market has been evaluated as a moderately growing market and it is expected to continue growing in the near future.

Increasing prevalence of salivary gland infections are major driver for the market growth.

Some other factors such as changing disease patterns, smoking, and changing environment are driving the growth of global salivary gland infection market.The market for salivary gland infection was around USD 2300.8 million in 2016 and is expected to reach USD 3622.6 million which is projected to grow at a CAGR of 6.7% by 2023.Major players in Salivary Gland Infection market:There are plenty of large and small market players which operate in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc.

Drug manufactures are investing large amount of money in new product development as well as improvement of existing product to derive efficient solution for market.

Top players are holding majority of market share while medium and small companies are also holding small but major piece of this market.WOCKHARDT’s a global pharmaceutical and biotechnology organization is under clinical development of its Second-generation Ketolide drug which can treat serious bacterial infections.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3779Regional Analysis:Considering the global scenario of the salivary gland infection market, in 2016, Americas was holding the largest market share in global salivary gland infection.

US is dominating and top revenue generator in Americas market that is mainly due to some factors like increasing investment research and clinical trials.

Mayur Kasrung 2021-08-17
img

Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific & the Middle East & Africa) - Global Forecast till 2027Market Research Future (MRFR) recognizes the following companies as the key players in the global prils market are Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG.Market HighlightsThe Prils Market is estimated to be valued at USD 2,591.5 million by 2023 and is expected to register a CAGR of 4.3% during the forecast period.Prils are small molecules or active pharmaceutical ingredients (API).

There are various types of APIs used by pharmaceutical companies to develop therapeutic products for the treatment of various chronic diseases such as hypertension, heart diseases, and kidney diseases.Segment analysisOn the basis of type, the global prils market is segmented into benazepril, cilazapril, quinapril, and ramipril.

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and mostly preferred drug for the treatment of hypertension.

The use of ramipril reduces the risk of stroke, heart attack, and also decreases kidney-related problems.

This drug normalizes blood vessels and offers normal blood flow.

Increasing smoking also causes cardiovascular diseases.

Mayur Kasrung 2021-08-17
img

Global Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2027Market HighlightsThe rising prevalence of angina and coronary heart diseases, growing healthcare expenditure, and increasing geriatric and obese population are expected to drive the global angina market, during the forecast period.

On the basis of treatment, the market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others.

The medication segment is sub-segmented into aspirin, clot-preventing drugs, statins, ranolazine, and others.

This can be attributed to the presence of a well-developed healthcare sector and a huge patient population for coronary heart diseases.

Availability of funds for research, growing number of obese and patient population, and the presence of developed economies such as France, Italy, and Germany within the region are the major drivers for the market growth within the region.

This can be attributed to the presence of poor economies, stringent government policies, and low per capita healthcare expenditure, especially within the African region.

Mayur Kasrung 2021-08-17
img

The global data analysis, storage & management market in life sciences is expected to register a CAGR of 12.0% during the forecast period and is expected to hit USD 43,895.69 million by 2027.Data analysis, storage, and management provides operational benefits to an organization by enhancing the efficiency of electronic data storage.

The data analysis, storage & management market in life sciences is growing due to the increasing government initiatives to increase the adoption of different data-based solutions and the growing demand for data storage and management solutions due to the extensive amount of data generated in the life science field.

Additionally, the increasing growth strategies adopted by major players are also driving the market growth.Segment AnalysisThe global data analysis, storage & management market in life sciences has been divided based on product & service, application, and end user.The market, based on product& service, has been segregated into data analysis software and workbenches, storage, management and cloud computing solution, data analysis services.Based on application,the medical testing market has been divided intobnext-generation sequencing, microscopy, chromatography, flow cytometry, spectroscopy, and others.On the basis of end user, the market is bifurcated into pharmaceutical and biotechnology companies, research centers, academic & government institutions, and hospitals & clinics.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/10317Regional AnalysisThe global data analysis, storage & management market in life sciences, based on region, has been divided into North America, Europe, Asia-Pacific, and the rest of the world.

North Americais expected to dominate with the largest market share due to a well-developed healthcare sector, the rising population affected with chronic diseases and other cardiovascular disorders, the growing use of big data in healthcare, and the presence of leading players.Europe held a significant share in the global data analysis, storage & management market in life sciences.

This can be attributed to the increasing support from the government, well-developed technology, high healthcare expenditure, the presence of the leading players, and rising adoption of big data analysis and cloud-based solutions.Asia-Pacific is expected to be the fastest-growing market due to the rapidly changing healthcare sector and huge opportunities for the development of this market.

Furthermore, the increase in per-capita healthcare expenditure, rise in diagnostic centers, and rapid urbanization in developing countries such as India are likely to witness an increase in the influx of the emigrant population.

Mayur Kasrung 2021-08-17
img

Asia Pacific Orthopedic Biomaterial Market Information, By Type Of Material (Metal, Non-Metal), By Application (Joint Replacement, Fracture Fixation Devices, Tissue Fixation, Spine Implants Viscosupplementation, And Others), And By End Users (Hospital, Clinics) - Forecast Till 2027Market Insights:As per the latest study published by Market Research Future (MRFR), the Asia Pacific orthopedic biomaterial market is poised to strike a CAGR of 12.6% during the forecast period 2017 to 2023.

The growth of the orthopedic branch of medicine coupled with rising demand for biomaterials for implants is likely to drive the growth of the Asia Pacific orthopedic biomaterial market in the upcoming years.The advancements in the medical science over the years has catalyzed the adoption of biomaterials for implants and surgeries.

Furthermore, the extensive use of biomaterials for the treatment of internal fractures is another factor responsible for driving the expansion of the Asia Pacific orthopedic biomaterial market.The rising demand for knee and hip replacements coupled with increasing medical emergencies and bone injuries in the region are projected to have a favorable impact on the proliferation of the Asia Pacific orthopedic biomaterial market over the assessment period.Other factors that are estimated to accelerate the revenue creation for the participants of the Asia Pacific orthopedic material market include rising aging population, increasing orthopedic surgeries, initiatives undertaken by governments, etc.

Nevertheless, stringent regulation, the high cost of treatment and joint implant failures are expected to restrict the Asia Pacific orthopedic biomaterial market expansion over 2023.Market Segmentation:By material, the Asia Pacific orthopedic biomaterial market has been segmented into metals and non-metals.

The non-metal segment has been further sub-segmented into ceramic, polymeric, natural biomaterials, and others.

The fracture fixation devices segment is sub-segmented into screws, plates for bones, rods, and other.By end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/643Regional Analysis:China is the most significant country-level market in the region.

Mayur Kasrung 2021-08-16
img

Hallux Rigidus Market Research Report: By Treatment (Non-Surgical Treatment And Surgical Treatment), Diagnosis (X-Ray, Ct Scan, And Mri), End-Users (Hospitals & Surgical Centers, Home Cares, And Orthopedic Specialty Clinics) – Global Forecast Till 2027Market Highlights:Hallux rigidus is an arthritic condition often leading to pain and stiffness within the joint located behind the big toe.

It leads to limitation in joint range of motion and painful ambulation.The Global Hallux Rigidus Market is expected to grow at a CAGR of 7.6% during the forecast period.Regional Analysis:The Americas dominate the global hallux rigidus market owing to the rising geriatric population, increase in genetic disorders and increasing number of surgical procedures in the hospitals.

North America holds the largest market owing to extensive use of advanced technology and developed pharmaceutical sector.Europe accounts for the second largest market due to increasing funds, government support, and increasing healthcare expenditure.

Germany, France, and the U.K hold a significant share in the market due to increasing demand for technologically advanced devices for the surgical procedures and overall growth of medical device industry.The Asia Pacific is the fastest growing market for the hallux rigidus, whose growth is attributed to rising geriatric population, increasing prevalence of people suffering from toe infections, and rapidly developing economies.

For instance, according to ESCAPE (Economic and Social Commission for Asia and the Pacific), in the year 2016, approximately 12.4% of the population was 60 years or older and is projected to increase to 1.3 billion people by 2050.

India and China are the major contributors to the market growth due to the rapid development of healthcare sector in these regions and increasing demand for diagnostic services.On the other hand, the Middle East & Africa is expected to witness limited growth due to limited access to the healthcare resources and lack of awareness about rare diseases.

Mayur Kasrung 2021-08-23
img

Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global Forecast Till 2027Market Highlights:Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart.

The market restraints are the poor cure rates, poor efficacy and efficiency of effective drugs etc.Global Wolff Parkinson White Syndrome Market PlayersKey players profiled in the report are AngioDynamics, Medtronic, Boston Scientific Corporation, St. Jude Medical, LLC, Abbott, GlaxoSmithKline LLC, Teva Pharmaceutical Industries, Sanofi S.A., and Novartis International AG and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4224Regional AnalysisThe Americas which are dominated by the US account for a significant market share owing to extensive use of medications and high expenditure on the health care.

Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Wolff Parkinson White syndrome market.

The good reimbursement scenario and the greater awareness in the developed regions drive the market.Europe is the second largest market in the world due to high income and healthcare penetration.

The presence of large screening programs in the developed regions drives the market for Wolff Parkinson White syndrome.Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market.

The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report.

Mayur Kasrung 2021-08-21
img

Vesicoureteral Reflux Market Research Information: by types (primary, secondary) by diagnosis (cystography, VCUG, others) by drug treatment (quinolones, aminoglycosides, others) by surgery (open, robotic, others) by end users - Global Forecast till 2027Market HighlightsVesicoureteral reflux (VUR), is a condition in which urine flows backward, from the bladder into the ureters/kidneys.

The normally flow of urine is unidirectional from the kidneys to the bladder via the ureters.

The backflow is prevented by a 1-way valve at the vesicoureteral junction.The market for Vesicoureteral reflux diagnosis and treatment is driven by factors such as growing prevalence of urinary tract infection, genetic predisposition and occurrence at birth (congenital), increasing screening etc.

Advances in surgical robots such as miniaturization improvements in planned and regulated movement, processing power etc.

Clinical benefits include reduced invasiveness, reduction of tissue trauma traditionally associated with open surgery, less surgeon fatigue due to better ergonomic position of the hands etc.

Product development strategy and growing awareness coupled with the rising penetration of healthcare will drive the market for Vesicoureteral reflux diagnosis and treatment.Request Free Sample Copy @ https://www.marketresearchfuture.com/reports/vesicoureteral-reflux-market-3982Global Vesicoureteral reflux market Players:Key players profiled in the report are Salix Pharmaceuticals, Q-Med Scandinavia Inc., Cook Medical, Salix Pharmaceuticals, Ltd., Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd and others.Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report.

Mayur Kasrung 2021-08-17
img

Specialty Medical Chairs Market Research Report, by Product Type (Examination Chair, (Birthing, Cardiac), Treatment Chair (Ophthalmic, ENT), Rehabilitation Chair (Geriatric, Pediatric)), Application (Medical Units, Hospital) — Global Forecast till 2027Market HighlightsIt is estimated that the global specialty medical chairs market is expected to register a CAGR ~6.8% during the forecast period of 2018–2023.The global specialty medical chairs market is expected to witness tremendous growth owing to the increasing incidence of obesity and a large number of laparoscopic surgeries performed.

However, factors such as lack of trained medical professionals are expected to curb the growth of the market during the forecast period.An increasing number of patients requiring treatment and examination favors the growth of the market.On a regional basis, the specialty medical chairs market in the Americas is predicted to dominate the market during the forecast period.

For instance, according to the American Hospital Association (AHA), an annual survey of hospitals in the US suggests the total number of registered hospitals in the US was 5,534 in 2017.

Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market.Currently, the global specialty medical chairs market is dominated by numerous players.

The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio.

For instance, Dentsply Sirona, Inc. focusing on the development of new products, updating existing products, and introducing advanced technology in products.

Mayur Kasrung 2021-08-17
img

Global Epilepsy Diagnosis & Treatment Market Research Report, By Type (Idiopathic, Cryptogenic, Symptomatic), Diagnosis (Neurological Exam, Blood Test, Imaging), Treatment (Medication, Surgery) End-User (Hospitals, Clinics) - Global Forecast Till 2027Market HighlightsIncreasing prevalence of epilepsy, rising number of traumatic brain injury cases, growing geriatric population, and rising healthcare expenditures are the major drivers for the global epilepsy diagnosis and treatment market.

However, high cost of therapeutic surgeries, low per capita healthcare expenditure, and lack of awareness for the disease in emerging economies are estimated to restrain the market growth during the projected period.

The imaging segment is sub-segmented into electroencephalogram, computerized tomography, magnetic resonance imaging, positron emission tomography, and others.

On the basis of treatment, the market is segmented into medication, surgery, brain stimulation, and others.

The brain stimulation segment is sub-segmented into deep brain stimulation, responsive neurostimulation, and others.

On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5647Regional AnalysisThe Americas dominate the global epilepsy diagnosis and treatment market, which can be attributed to the presence of a well-developed healthcare sector and huge patient population within the region.

Mayur Kasrung 2021-08-17
img

Global Mitochondrial Myopathy Diagnosis & Treatment Market Research Report: Information by Type (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes, Progressive External Ophthalmoplegia, Myoclonic Epilepsy with Ragged Red Fibers, Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, Kearns–Sayre Syndrome (KSS), Mitochondrial DNA Depletion Syndrome, Pearson Syndrome, Leigh Syndrome, Neuropathy, Ataxia and others), Diagnostic Test (Genetic Tests, Muscle Biopsy and Biochemical Test), Deployment Models (On-Premise and Cloud-Based), Therapy (Supportive Therapy and Targeted Therapy) and Region - Forecast Till 2027In Mitochondrial myopathy, the mitochondria are affected which leads to symptoms such as muscle weakness, muscle cramping, low immunity, poor balance, and fatigue.

The spiraling rise in the incidence rate of mitochondrial myopathy is a key factor in boosting the growth of the market.

In addition, rigorous R activities aimed at developing therapies and treatments for mitochondrial myopathy have encouraged the growth of the market.

Lack of proper curative treatment and poor treatment options remain a major hurdle for the market growth.

Besides, the rare nature of the disease and high cost of drug development along with high investment risk remain major challenges to the growth of the market.

Nevertheless, faster market uptake and low marketing cost are likely to present growth opportunities to the global mitochondrial myopathy diagnosis & treatment market.SegmentationThe global mitochondrial myopathy diagnosis & treatment market has been segmented based on type, diagnostic tests, and therapy.By type, the global mitochondrial myopathy diagnosis & treatment market has been segmented into neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), progressive external ophthalmoplegia (PEO), Pearson syndrome, Leigh syndrome, ataxia, mitochondrial DNA depletion syndrome (MDS), Retinitis pigmentosa (NARP), Kearns–Sayre syndrome (KSS), myoclonic epilepsy with ragged red fibres (MERRF), mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE).

Mayur Kasrung 2021-08-17
img

LDL Test Market Information: By Types (LDL-C, LDL-P, LDL-B And Others) By Components (Devices, Kits & Reagents And Others) By Application (Atherosclerosis, Obesity, Dyslipidemia, Diabetes, Angina, Stroke, Carotid Artery Disease, Peripheral Arterial Disease, Others) And By End Users- Global Forecast Till 2027Market Highlights:LDL is referred as low-density lipoprotein, which is type of cholesterol found in body.

Low-density lipoprotein (LDL), often known as bad cholesterol, is a microscopic blob made up of an outer rim of lipoprotein and a cholesterol center.

It's bad because it becomes part of plaque, and that can clog arteries and make heart attacks and strokes more likely.

The global LDL test market is projected to grow at a CAGR of ~ 5.5 % during the forecast period 2017-2023.Key Market PlayersQuest Diagnostics Incorporated, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckon Diagnostics, DiaSys Diagnostics India Private Limited, F. Hoffmann-La Roche Ltd and others.

Also, major research and manufacturing companies are present in America.Europe is the second largest market in the world due to high income, government support for research & development and availability of resources.Asia Pacific region shows the fastest growth owing to the presence of huge population base, and continuous development in the healthcare sector.

The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.Taste the market data and market information presented through more than 55 market data tables and figures spread over 110 pages of the project report.

Mayur Kasrung 2021-08-16
img

Global Hypotension Treatment Market Research Report: By Products (Blood Pressure Transducers, Sphygmomanometers, Blood Pressure Devices), By End-Users (Diagnostic Centers, Home Care, Hospitals & Clinics) and Regions (Europe, Americas, Middle East & Africa, Asia Pacific) – Forecast to 2027Industry Analysis:The worldwide low blood pressure or hypotension market is driven by various factors.

Dehydration, endocrine disorders, and nerve issues can also cause hypotension, leading to further market growth.

Low blood pressure patients often feel dizzy and weak, which is why, they are recommended several medicines to maintain stability and good health.Teenagers and post-partum mothers are also impacted by hypotension.

The presence of cardiac & diabetic patients has increased stress on developing & developed nations.

Some of the eminent companies spending capital on the hypotension treatment industry are Shire plc, Hoffman-La Roche Limited, and Amgen, Inc.

A novel drug, Droxidopa, sold as Northera, was sanctioned to manage multiple-system atrophy, Parkinson’s disease, and pure autonomic failures.

Mayur Kasrung 2021-08-16
img

Global Phototherapy Market Research Report: Information By Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, Fiberoptic Phototherapy Equipment, Germicidal lamps and Accessories), Radiation (UVA, UVB and UVC), Application (Skin Disease Treatment, Neonatal Jaundice Management and Sterilization), End User (Hospital & Clinic, Dermatology Center and Homecare) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast to 2027Market OverviewGlobal Phototherapy Market is expected to reach USD 764.5 Million by 2027 at a CAGR of 4.61% during the forecast period.

Market Research Future (MRFR), in its report, offers an in-depth look into the market during the review period.Segmental AnalysisGlobal Phototherapy Market has been segmented based on Product, Radiation, Application, and End User.Based on product, the global phototherapy market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories.

The conventional phototherapy equipment segment dominated the market with a valuation of USD 184.0 million in 2019; it is expected to reach a valuation of USD 250.5 million by 2027.

The conventional phototherapy equipment comes with a fluorescent lamp for full-body or partial-body phototherapy.Based on radiation, the global phototherapy market has been classified into UVA, UVB, and UVC.

Narrowband UVB is frequently used because it is more effective for treating psoriasis than UVA or Broadband UVB.Based on application, the global phototherapy market has been classified into skin disease treatment, neonatal jaundice management, and sterilization.

Neonatal jaundice is referred to the yellowing of the skin and white part of the eyes of a new-born baby due to a high level of bilirubin.